Skip to main content
TVGNW logo

TVGNW · Tevogen Inc.

Track TVGNW — free
$0.06 +0.00 (+2.86%) At close · Oct 21
Market Cap
$44.41M
Shares
6.51M
Volume · Oct 21 836.13K Avg daily vol (3M) 405.79K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.06 Open$0.06 Day$0.06–0.07 Available close range$0.04–0.08 Avg vol 30d401K DataJul 2026–Oct 2026 Filing10-Q · Aug 14

The closing range uses available history since Jul 23, 2026; less than a full year is stored.

Up next

filed Aug 14, 2026

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
7 of 63 funds reported for Sep 30 · net -867 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
63 holders — mid 3-yr range
Price context
position in its available closing range
Range low $0 Now $0 · 60% Range high $0
vs 50-day avg +13%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TVGNW
Tevogen Inc.
this stock
$44.41M — — — —
VRTX
Vertex Pharmaceuticals Inc
$131.39B +15.7% +46.2% 30.2 1.8%
MRNA
Moderna, Inc.
$98.14B +733.5% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
$83.13B +4.4% +20.8% 20.0 2.1%
CSLLY
Csl Ltd
$66.22B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
61
% held
155.6%
Reported
7 of 63
Top holder
FourWorld Capital Managem…
Held Float
View
Short & Settlement
Fails to Deliver
FTD shares
47
Value
$367
As of
Sep 23, 2026
View
Financials
Financials
Net income (FY)
$-26.3M
EPS diluted
$-8.08
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 30, 2026
This year
19
View
Proposed Sales
Value
$103.2K
Shares
330.0K
Filed
Feb 6, 2026
View
Earnings & Events
Investor Relations
Latest news
Tevogen Bio Holdings Inc. Becomes…
Published
Jul 29, 2026
View

Performance

5D 20D 120D MTD YTD
TVGNW -7.2% +6.8% — -6.8% —
SPY +0.5% +0.7% +7.6% +1.4% +13.4%
vs SPY -7.6% +6.1% — -8.1% —
Key facts CIK 1860871 CUSIP 88165K200 Visit website Investor relations